Biotechnology News

May 1, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. today announced its first-quarter 2012 financial results.

May 1, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Deutsche Bank 37th Annual Healthcare Conference, being held May 7-9, 2012 at the InterContinental Hotel in Boston....

May 1, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE):   ($ in millions, except per share amounts)     First-Quarter 2012   2011(4)   Change Reported Revenues $ 15,405 $ 16,502 (7 %) Adjusted Income(1) 4,432 4,808 (8 %) Adjusted Diluted EPS(1) 0.58...

May 1, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today reported financial results for the first quarter ending March 31, 2012

May 1, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2012 results. First...

May 1, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides to present corporate summary in the OneMedPlace Emerging Companies Showcase at the 21st annual NYBA meeting in NYC. Free for investors and other interested parties to attend.

May 1, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead to Report Fiscal 2012 Second Quarter Financial Results Conference Call Scheduled for Tuesday, May 8, 2012

May 1, 2012

FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation, a global provider of innovative assay solutions used in assay development, drug screening and profiling, announced that its PathHunter assays are gaining widespread adoption in large...

May 1, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals is announcing their participation and presentation details at the 37th Annual Deutsche Bank Health Care Conference in Boston, MA on May 8th.

May 1, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex announces that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012 at 5:00 p.m. ET.

May 1, 2012

VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it has completed the previously announced acquisition of World Courier Group, Inc., a privately held leading global specialty transportation and...

May 1, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical...

May 1, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the first quarter...

May 1, 2012

OKLAHOMA CITY & AUSTIN, Texas--(BUSINESS WIRE)--Caisson Biotech has entered into a Development and License Agreement with Novo Nordisk, a global leader in diabetes care, giving exclusive rights to Caisson’s heparosan-based drug delivery...

May 1, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, is pleased to announce the acquisition of a state-of-the-art, high-speed blister line for their new...

May 1, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573) has announced today that it has been notified by the International Court of Arbitration, International Chamber of Commerce (ICC), that the anticipated date of the arbitration decision in its...

April 30, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced it will host a conference call and...

April 30, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it will host a teleconference and webcast with management to provide a general business overview, as well as to discuss its first quarter 2012 financial results...

April 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today reported financial results for the third quarter of fiscal 2012. Array reported revenue of $19.1 million for the third quarter of fiscal 2012, compared to revenue of $17.8...

April 30, 2012

DENVER--(BUSINESS WIRE)--PIUG 2012 Annual Conference – Questel, a leader in online information services for over 40 years, and GenomeQuest, a global provider of large-scale genomic software applications, announced today a partnership to integrate...

April 30, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Present at Deutsche Bank Health Care Conference

April 30, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Hearing Technologies is excited to announce that its AMP hearing aid has been honored with a 2012 Silver Edison Award in the category of Science/Medical-Assistive Devices.

April 30, 2012

BORDEAUX, France & AUSTIN, Texas--(BUSINESS WIRE)--Today eDevice introduced HealthGO, a complete technology platform for Remote Patient Monitoring based on Freescale Semiconductor’s Home Health Hub (HHH) reference platform. HealthGO is a...

April 30, 2012

SANTA ROSA, Calif.--(BUSINESS WIRE)--Direct Flow Medical, Inc., a privately held, emerging medical device company focused on the next generation, minimally invasive implant to treat patients with heart valve disease announced the appointment of...

April 30, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--HepatoChem is a revenue-generating early stage life science company that has been awarded a $330,000 Program loan from the Massachusetts Life Sciences Center.

April 30, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Deutsche Bank Securities 37th Annual Health Care Conference...

April 30, 2012

PLANO, Texas--(BUSINESS WIRE)--PERSONALIZED WOMEN’S HEALTHCARE OF PLANO PIONEERS BREAST CANCER RISK ASSESSMENT

April 30, 2012

MIRAMAR, Fla.--(BUSINESS WIRE)--Altor BioScience Corporation (Altor), a leading developer of immunotherapeutics for curative treatment of metastatic malignancies, announced today that it will jointly sponsor with the Melanoma Research Alliance (...

April 30, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that annual fees related to the U.S. Affordable Care Act which will be levied on drug...

April 30, 2012

DENVER--(BUSINESS WIRE)--Stryker Sustainability Solutions has co-founded a coalition of elite healthcare suppliers to advance the purchase of products and processes that lower hospital environmental impact.

April 30, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, was honored to be the Sponsor and an Exhibitor at the 7th national...

April 30, 2012

CONCORD, Calif. & BERN, Switzerland & GENEVA--(BUSINESS WIRE)--Cerus, the University Hospitals of Geneva and the Swiss Red Cross Transfusion Service intend to collaborate on adapting the Cerus INTERCEPT red cell system to improve blood...

April 30, 2012

NEW YORK--(BUSINESS WIRE)--TKL Research, a clinical research organization (CRO), has selected Medidata CTMS as part of an initiative to expand its clinical trial operations.

April 30, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (TEVA), one of the world’s largest producers of pharmaceuticals, announces that it has settled patent infringement litigation regarding U.S. Patent Number 7,132,570 (the "'570 patent...

April 30, 2012

NEW YORK--(BUSINESS WIRE)--NLV Partners General Partner Dr. Liam Ratcliffe joins Array BioPharma Board of Directors as independent director.

April 30, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Israel tops the list of countries in medical device patents per capita and is fourth worldwide for biotechnology patents per capita

April 30, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Deutsche Bank 37th Annual Health Care Conference in Boston on Monday, May 7, 2012. José E. Almeida, Chairman, President...

April 30, 2012

SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that it will release its first quarter ended March 31, 2012 financial results on Thursday, May 10, 2012 before the open...

April 30, 2012

BETHESDA, Md.--(BUSINESS WIRE)--GE Capital, Healthcare Financial Services announced today that it was sole lender and administrative agent on $7.5 million in senior secured credit facilities for PharmAthene, consisting of a $2.5 million term loan...

April 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) announced that it has elected Liam Ratcliffe, M.D., Ph.D., to its Board of Directors as an independent director. Dr. Ratcliffe has extensive background in drug development and...

April 30, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) will present at the 37th Annual Deutsche Bank Health Care Conference on Tuesday, May 8, in Boston. John Heinmiller, executive vice president and chief financial officer, will...

April 30, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent...

April 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will webcast its presentation at the Deutsche Bank 37th Annual Health Care Conference in Boston. Harvey J. Berger, M.D., chairman and chief...

April 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus completed enrollment in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate Synavive® in patients with rheumatoid arthritis (RA)

April 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) announced today that Dr. Walter C. Herlihy, President and Chief Executive Officer of Repligen, will host a conference call and webcast on Thursday, May 3, 2012 at 8:30 a.m. EDT....

April 30, 2012

NES ZIONA, Israel--(BUSINESS WIRE)--Kadimastem announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.

April 30, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda, a Westchester-based biopharma developing therapies to improve the lives of people living with MS, SCI, and other nervous system disorders, named one of the best companies to work for in NY.

April 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that the company’s management will present a company overview at upcoming investment conferences. Tuan Ha-Ngoc, president and chief executive officer, is...